Inhalation and Nasal Spray Generic Drugs Market by Indication Types (Allergic Rhinitis, Asthma, COPD), Therapeutic Drug Classes (Antihistamines, Bronchodilators – Albuterol, Epinephrine; Combination Drugs – Azelastine (Benzalkonium Chloride), Formoterol (Budesonide), Salmeterol (Fluticasone); Corticosteroids – Beclomethasone, Budesonide, Flunisolide, Fluticasone; Decongestant Sprays – Phenylephrine and Oxymetazoline Hydrochlorides) and Forecast 2017-2021

Inhalation and Nasal Spray Generic Drugs Market by Indication Types (Allergic Rhinitis, Asthma, COPD), Therapeutic Drug Classes (Antihistamines, Bronchodilators – Albuterol, Epinephrine; Combination Drugs – Azelastine (Benzalkonium Chloride), Formoterol (Budesonide), Salmeterol (Fluticasone); Corticosteroids – Beclomethasone, Budesonide, Flunisolide, Fluticasone; Decongestant Sprays – Phenylephrine and Oxymetazoline Hydrochlorides) and Forecast 2017-2021

Intranasal medication delivery is important for both specifically developed pharmaceutical drugs designed for intranasal treatment, as well as for investigating off label uses of commonly available generic medications. Nasal sprays for local effect are quite common. Steroids, antiasthma medications such as salbutamol, ipratropium, montelukast and a large number of inhalational anaesthetic agents are being commonly used. Increase in the incidence of chronic obstructive pulmonary disease, asthma, and other fatal respiratory disorders are driving the global inhalation and nasal spray generic drugs market.

The global inhalation and nasal spray generic drugs market report estimates the market size (Revenue USD million – 2014 to 2021) for key market segments based on the indication type (allergic rhinitis, asthma, COPD, etc.), therapeutic drug classes (antihistamines, bronchodilators – albuterol, epinephrine; combination drugs – Azelastine (benzalkonium chloride), Formoterol (budesonide), Salmeterol (fluticasone); Corticosteroids – beclomethasone, budesonide, flunisolide, fluticasone; decongestant sprays – phenylephrine and oxymetazoline hydrochlorides), and forecasts growth trends (CAGR% – 2017 to 2021).

The global inhalation and nasal spray generic drugs market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global inhalation and nasal spray generic drugs market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global inhalation and nasal spray generic drugs market and included in this report are Teva Teva Pharmaceutical Industries Ltd., Sandoz International GmbH (Novartis AG), Allergan plc, Mylan N.V., Ranbaxy Laboraotries Ltd., Roxane Laboratories, Inc., Beximco Pharmaceuticals Ltd., Cipla Ltd., and Nephron Pharmaceuticals Corporation.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Drugs
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Drug Class or Drug (Brand) Type
    • Drug or Disorder Test
    • Indication Type
    • Drug Treatment
    • Mechanism of Action
    • Therapeutic Area or Nature of Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • IND, NDA filed, FDA, EMEA Approvals
  8. Pipeline Analysis(Phase 1, 2 and 3 Drugs)
    • Phase 3 Drugs Forecast Estimation (Approval to 2025)
    • Phase 1 and 2 Drugs – Qualitative Analysis
  9. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  10. Recommendations
  11. References

Inhalation and Nasal Spray Generic Drugs Market

1. Drug Class
1.1. Antihistamines
1.2. Bronchodilators
1.2.1. Albuterol
1.2.2. Epinephrine
1.2.3. Others
1.3. Combinations
1.3.1. Azelastine (Benzalkonium Chloride)
1.3.2. Formoterol (Budesonide)
1.3.3. Salmeterol (Fluticasone)
1.3.4. Others
1.4. Corticosteroids
1.4.1. Beclomethasone
1.4.2. Budesonide
1.4.3. Flunisolide
1.4.4. Fluticasone
1.4.5. Others (Ciclesonide, Mometasone)
1.5. Decongestant Sprays
1.5.1. Phenylephrine Hydrochloride
1.5.2. Oxymetazoline Hydrochloride
2. Indication
2.1. Allergic Rhinitis
2.2. Asthma
2.3. Chronic Obstructive Pulmonary Disease (COPD)
2.4. Other Respiratory Disorders

3. Company Profiles
3.1. Allergan plc.
3.2. Beximco Pharmaceuticals
3.3. Cipla Ltd.
3.4. Mylan N.V.
3.5. Nephron Pharmaceuticals Corporation
3.6. Ranbaxy Laboratories Ltd.
3.7. Roxane Laboratories, Inc.
3.8. Sandoz International GmbH (Novartis AG)
3.9. Teva Pharmaceutical Industries Ltd.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*

Translate »